A competitor’s patent may describe a technology that looks uncomfortably close to your product. That alone does not establish liability. The practical question is what makes a patent infringed: whether a product, process, or commercial act falls within the legally construed scope of at least one enforceable patent claim in the relevant country.
For founders and technical teams, this distinction matters. Product similarity can justify concern, but infringement analysis requires a disciplined comparison between claim language and technical facts. A single missing claim feature can be decisive. Equally, a feature that appears absent at first sight may still create risk where the claim is interpreted more broadly than expected.
What makes a patent infringed under the claims?
A patent is not infringed simply because someone has used the same general idea, achieved the same result, or built a more advanced version of a known product. The legal boundary is set by its claims. Each independent claim defines a combination of technical features that must be assessed against the accused product or process.
The starting point is usually straightforward: identify an enforceable claim and map every required feature to the product, method, software operation, manufacturing step, or component under review. If all required features are present, infringement may arise. If one required feature is genuinely absent, literal infringement of that claim will usually fail.
Consider a claim requiring a sensor, a processor configured to calculate a specified value, and a display that presents the result in a particular way. A device containing a sensor and processor may still avoid the claim if it does not perform the required calculation or lacks the defined display function. Conversely, a product team should not assume that changing a component’s label, form factor, or internal architecture avoids risk if it continues to perform the claimed technical function.
This is why a proper claim chart is more useful than a high-level patent summary. It forces the analysis to answer a clear question for each limitation: where, precisely, is this feature found in the product or process? Technical documentation, source code, circuit diagrams, test data, marketing material, user manuals, and physical inspection may all be relevant evidence.
Claim interpretation comes before comparison
Claims are read through the eyes of the skilled person, using the patent specification and common technical knowledge to understand their meaning. The wording matters, but the analysis is not always a narrow dictionary exercise.
In the UK and other European contexts, courts assess what the skilled reader would understand the patent to mean. In certain cases, a variant that does not fall within the ordinary meaning of the words may nevertheless be treated as infringing if it achieves substantially the same result in substantially the same way and the variation would not be regarded as material by the skilled person. The precise approach depends on jurisdiction and the facts.
That creates a commercially significant trade-off. A design-around that is technically different may reduce risk, but a superficial substitution may not. The more central the substituted feature is to the invention, the more carefully the alternative should be assessed and documented.
The acts that can amount to patent infringement
Infringement is not limited to making a product. In the UK, an enforceable patent can generally be infringed by making, disposing of, offering to dispose of, using, importing, or keeping a patented product for those purposes without consent. Using a patented process, or dealing in a product obtained directly from that process, can also create exposure.
The commercial act matters as much as the technology. A business may face risk before its first sale if it imports stock, offers the product for sale, or uses a patented manufacturing method. Demonstrators, pilot installations, and contract-manufacturing arrangements should therefore be considered within the review.
There can also be indirect infringement. This may arise where a party supplies or offers to supply means relating to an essential element of the invention, knowing — or where it is obvious — that those means are suitable and intended to put the invention into effect in the UK. Components with substantial non-infringing uses require a more fact-specific assessment. The supplier’s knowledge, intended use, customer instructions, and the nature of the component can become central.
A useful distinction is between private experimentation and commercial activity. Some statutory exceptions may apply in limited circumstances, including certain experimental uses. They are not a safe assumption for product development, commercial trials, or market entry. The scope of any exception should be reviewed against the planned activity, not relied upon as a general comfort statement.
A patent must be enforceable in the relevant territory
Patent rights are territorial. A UK patent does not automatically prevent manufacture in Germany, sales in France, or use in the United States. European patent protection also needs careful attention: a European patent is not one unitary right in every respect, and the relevant validated national rights, Unitary Patent coverage where applicable, and court framework must be identified.
The first practical questions are therefore where the product is made, assembled, tested, stored, imported, sold, and used. For a connected product, the analysis may also need to consider where relevant system steps occur. For a process claim, the place of performance and the movement of products directly obtained by the process can be critical.
Timing matters as well. A published patent application can create commercial uncertainty, but enforceable rights and available remedies depend on its legal status, jurisdiction, and the applicable rules. An expired patent cannot be infringed through future acts, while a lapsed patent may sometimes be restored. Patent registers, renewal status, ownership records, and claim amendments should be checked rather than assumed.
Validity and infringement are different questions
A claim can be technically relevant to your product and still be vulnerable to invalidity. Prior art may show that the claimed invention was not new or inventive. The claim may be insufficiently disclosed, added matter may be an issue, or an amendment may have narrowed or altered the enforceable scope.
However, a potential invalidity argument is not the same as commercial freedom to operate. Until a court or competent authority revokes or limits the patent, an apparently weak patent can still be asserted and can still disrupt a launch, investment round, supply agreement, or acquisition. A defensible position requires both sides of the analysis: does the claim cover the planned activity, and how likely is the claim to withstand challenge?
This is also why product teams should avoid treating a favourable prior-art search as a complete infringement answer. Prior art informs validity. Infringement depends on the claims as they stand and the actual product or process.
Evidence determines the strength of the position
An allegation becomes commercially serious when it is supported by evidence of use. For an external product, publicly available materials may show only part of the technical picture. A patent owner may rely on product samples, reverse engineering, user documentation, regulatory filings, manuals, public demonstrations, or disclosures made during sales discussions.
For your own product, preserve a clear technical record. Design specifications, version histories, development decisions, test protocols, supplier communications, and manufacturing records can establish what the product does, when it did it, and why a particular design choice was made. This evidence is valuable whether you are assessing exposure, responding to an allegation, or demonstrating that a proposed design-around has been implemented.
Confidentiality deserves equal care. A request for technical information from a competitor, customer, or distributor may have strategic implications. Provide no unnecessary admissions or incomplete technical explanations before the patent position and communication strategy have been assessed.
How to assess risk before it becomes a dispute
The right review is proportionate to the commercial decision. A broad freedom-to-operate study may be appropriate before entering a new market or committing to tooling. A focused infringement analysis may be more effective where a competitor has identified a particular patent. In both cases, the work should begin with a precise product definition, relevant territories, intended acts, and a realistic launch timetable.
A structured analysis normally identifies the patents most likely to matter, confirms their status and ownership, construes the relevant claims, and maps those claims to the available technical evidence. The outcome should not merely say “high” or “low” risk. It should explain the decisive features, the evidence gaps, the possible design changes, and the options for licensing, opposition, invalidity work, or controlled market entry.
TIPAG delivers this type of technical patent analysis with the engineering detail needed for commercial decisions. Where legal representation or formal proceedings are required, independent patent attorneys can be involved while the technical evidence and claim mapping remain tightly managed.
The most useful time to ask whether a patent is infringed is before a design is frozen, tooling is ordered, or a launch promise is made. A clear claim-by-claim assessment gives your team room to choose: change the product, challenge the right, seek permission, or proceed with evidence-based confidence.